OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety
Ahmed Elfadadny, Rokaia F. Ragab, Rania Hamada, et al.
Toxicology and Applied Pharmacology (2023) Vol. 461, pp. 116405-116405
Closed Access | Times Cited: 22

Showing 22 citing articles:

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 239

Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies
Ahmed Elfadadny, Rokaia F. Ragab, Maha Alharbi, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 20

Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management
Dong‐Oh Moon
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2911-2911
Open Access | Times Cited: 9

Role of GPCR Signaling in Anthracycline-Induced Cardiotoxicity
Nimish Biswal, Ritika Harish, Mohsin H. K. Roshan, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 169-169
Open Access

Bioinspired nickel oxide nanoparticle as an efficient nanocarrier in the delivery of doxorubicin as an anti-bladder cancer drug
Yong-Chang Lv, Effat Esmaeili Shahri, A.H. Mahmoudi, et al.
Inorganic Chemistry Communications (2023) Vol. 152, pp. 110650-110650
Closed Access | Times Cited: 19

A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy
Shaghayegh Saharkhiz, Atefeh Zarepour, Negar Nasri, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106600-106600
Open Access | Times Cited: 16

Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
Yun Qiu, Piao Jiang, Yingmei Huang
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 16

New Transferrin Receptor-Targeted Peptide–Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity
Jiale Yu, Xiaoxia Mao, Xue Yang, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1758-1758
Open Access | Times Cited: 2

Effects of barakol from Cassia siamea on neuroblastoma SH-SY5Y cell line: A potential combined therapy with doxorubicin
Orapin Wongsawatkul, Paiwan Buachan, Yamaratee Jaisin, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24694-e24694
Open Access | Times Cited: 1

Anticancer, Antioxidant, Antimicrobial Activities, and HPLC Analysis of Alcoholic Extracts of Parthenocissus quinquefolia L. Plant Collected from Çanakkale
Ferah Cömert Önder, Sevil Kalın, Özlem Maraba, et al.
Journal of Advanced Research in Natural and Applied Sciences (2024) Vol. 10, Iss. 1, pp. 116-133
Open Access | Times Cited: 1

Targeted drug-loaded peptides induce tumor cell apoptosis and immunomodulation to increase antitumor efficacy
Hongjie Li, Peirong Zhang, Xiaomeng Yuan, et al.
Biomaterials Advances (2024) Vol. 160, pp. 213852-213852
Closed Access | Times Cited: 1

Unravelling the role of natural and synthetic products as DNA topoisomerase inhibitors in hepatocellular carcinoma
Qing Ren, Guoming Chen, Qi Wan, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107860-107860
Closed Access | Times Cited: 1

Elucidating the Prognostic and Therapeutic Significance of TOP2A in Various Malignancies
Guangchao Liu, Wenlong Lin, Kaifeng Zhang, et al.
Cancer Genetics (2024) Vol. 288-289, pp. 68-81
Closed Access

Novel inhibitor against Rac1 for therapeutic approach in prevention of breast cancer progression
Anudwipa Singh, Tirthankar Koley, Deepak Vats, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Drugs Commonly Used in Fungal Infection Risk Conditions Promote Drug Tolerance or Resistance in Candida albicans
Martin Obermeier, Margy Alejandra Esparza Mora, Oliver Heese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Mitochondrial ALDH2 improves ß‐cell survival and function against doxorubicin‐induced apoptosis by targeting CK2 signaling
Udayakumar Karunakaran, Eun Yeong Ha, Suma Elumalai, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 6, pp. 684-692
Open Access

Dehydroandrographolide ameliorates doxorubicin-mediated cardiotoxicity by regulating autophagy through the mTOR-TFEB pathway
Yongzhen Duan, Peixian Huang, Lu Sun, et al.
Chemico-Biological Interactions (2024) Vol. 399, pp. 111132-111132
Closed Access

Co-culture system of breast cancer and normal cells to investigate inflammation: using doxorubicin encapsulated in adipose-derived exosomes
Moein Shirzad, Abdolreza Daraei, Hossein Najafzadehvarzi, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access

Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future
Eva Řiháčková, Michal Říháček, Mária Vyskočilová, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 1

Tellimagrandin-I and camptothin a exhibit chemopreventive effects in Salmonella enterica serovar Typhimurium strains and human lymphocytes
Amanda Silva Fernandes, Abel Vieira de Melo Bisneto, Luana Santos Silva, et al.
Journal of Toxicology and Environmental Health (2023) Vol. 87, Iss. 5, pp. 185-198
Closed Access

Recent advances in the cardiotoxicity of anti-cancer drugs: Navigating the landscape of anthracycline-induced cardiotoxicity
Mark Chandy, Daniel J. Conklin
Toxicology and Applied Pharmacology (2023) Vol. 482, pp. 116791-116791
Open Access

Page 1

Scroll to top